Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
Clinical trial NCT07229157 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07229157
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-22
- Primary completion
- 2026-08-26
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.